Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4333773 | 0.84 | ADH1A (0.32) | ADH1CADH1A | |
| SCHEMBL1775545 | 0.73 | KMT2A (0.42) | HRH4HRH3MEN1KMT2AALDH1A1 | |
| SCHEMBL379571 | 0.71 | THRB (0.35) | — | |
| SCHEMBL17750056 | 0.71 | CYP1A2 (0.34) | — | |
| SCHEMBL3889901 | 0.70 | SHBG (0.33) | — | |
| SCHEMBL11775946 | 0.68 | ADH1A (0.35) | HRH4HRH3MEN1KMT2AALDH1A1 | |
| SCHEMBL28155611 | 0.67 | THRB (0.32) | — | |
| SCHEMBL467904 | 0.67 | KDM4E (0.37) | MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL170201 | 0.66 | ADH1A (0.48) | HRH4HRH3ALDH1A1ADH1CADH1A | |
| SCHEMBL21180049 | 0.66 | ADH1A (0.48) | HRH4HRH3ALDH1A1ADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220142905-A1 | COSMETIC PRODUCT CONTAINING A MIXTURE OF SILICONES | HENKEL AG & CO. KGAA (DE) | 2022-05-12 | — | — | US | disclosed |
| US-11213476-B2 | Method for gentle, chemical hair treatment | HENKEL AG & CO. KGAA (DE) | 2022-01-04 | — | — | US | disclosed |
| US-20200138694-A1 | METHOD FOR GENTLE, CHEMICAL HAIR TREATMENT | HENKEL AG & CO. KGAA (DE) | 2020-05-07 | — | — | US | disclosed |
| US-8304023-B2 | coating with a condensation-curable organopolysiloxanes with silanes to form elastomeric films insoluble in toluene; formed layer has a permanent soft hand and good bulk, no yellowing, free of volatile organic compounds; storage stability, solvent-free | WACKER CHEMIE AG (DE) | 2012-11-06 | — | — | US | disclosed |
| EP-1721926-B1 | Process for the production of dispersions of cross linked organopolysiloxanes | WACKER CHEMIE AG (DE) | 2009-07-01 | — | — | EP | disclosed |
| US-20080107814-A1 | Treatment Of Fiberfill Fibers With Aqueous Dispersions Of Organopolysiloxanes | WACKER CHEMIE AG (DE) | 2008-05-08 | — | — | US | disclosed |
| US-20080064813-A1 | METHOD FOR PRODUCING CROSSLINKABLE ORGANOPOLYSILOXANE DISPERSIONS | WACKER CHEMIE AG (DE) | 2008-03-13 | — | — | US | disclosed |
| EP-1721926-A1 | Process for the production of dispersions of cross linked organopolysiloxanes | Wacker Chemie AG (DE) | 2006-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200138694-A1 | METHOD FOR GENTLE, CHEMICAL HAIR TREATMENT | KRT18, POLR1C, TUBA1C | HRH4 2255/4885HRH3 2363/4885MEN1 3803/4885 |
| US-11213476-B2 | Method for gentle, chemical hair treatment | KRT18, POLR1C, TUBA1C | HRH4 2255/4885HRH3 2363/4885MEN1 3803/4885 |
| US-20220142905-A1 | COSMETIC PRODUCT CONTAINING A MIXTURE OF SILICONES | SQLE, LIPA, HSD17B4 | HRH4 2251/4885HRH3 1286/4885MEN1 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.